CODAC CEO Linda Hurley addresses the impact of delayed federal rules that would have expanded telehealth prescribing for buprenorphine. The postponement leaves CODAC patients and providers in limbo, highlighting the urgent need for stable policies to ensure continued access to life-saving OUD treatment.
Courtesy of the editor of Addiction Treatment Forum.
Recent Comments